Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Derek Watson

Physical Medicine & Rehabilitation Raleigh, NC Medical Doctor

NPI 1255524435 CMS profile 968809

11200 Governor Manly Way Ste 309, Raleigh, NC 27614

Open in the dashboard

General payments

$2,253

64 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Derek Watson of Raleigh, NC is reported in the CMS Open Payments database as having received $2,253 across 64 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $737 25
2024 General $182 3
2023 General $701 15
2022 General $162 2
2021 General $230 6
2020 General $72 4
2019 General $168 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Derek Watson
  • Physical Medicine & Rehabilitation median
  • Middle half of Physical Medicine & Rehabilitation
  • National median

In program year 2025, general payments to Derek Watson were reported at $737. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.

Show as a table
Year Derek Watson Physical Medicine & Rehabilitation median Middle half National median
2019 $168 $133 $45–$390 $163
2020 $72 $88 $29–$272 $114
2021 $230 $116 $33–$360 $132
2022 $162 $123 $40–$378 $149
2023 $701 $131 $43–$396 $160
2024 $182 $141 $45–$409 $164
2025 $737 $139 $48–$410 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $710 24 payments
  2. Relievant Medsystems, Inc. $615 11 payments
  3. Nevro Corp. $382 8 payments
  4. SI-BONE, Inc. $158 2 payments
  5. Ferring Pharmaceuticals Inc. $123 7 payments
  6. Flexion Therapeutics, Inc. $100 5 payments
  7. Medtronic, Inc. $48 2 payments
  8. Fidia Pharma USA Inc. $43 2 payments
  9. Globus Medical, Inc. $27 1 payment
  10. Medline Industries, Inc. $26 1 payment
  11. Other $22 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,026 62 payments
  2. Travel and Lodging $226 2 payments
Products named General payments · program years 2019–2025
  1. Intracept Intracept Access Instruments - Additional VB (Gen 3)_NMOD $636 22 payments
  2. Intracept Pain $615 11 payments
  3. Intracept Pain $615 11 payments
  4. Intracept Pain $615 11 payments
  5. Intracept Pain $615 11 payments
  6. Omnia $230 6 payments
  7. Senza $135 1 payment
  8. EUFLEXXA $123 7 payments
  9. Zilretta $100 5 payments
  10. Intracept Intracept Access Instruments (Gen 3)_NMOD $66 1 payment
  11. Other $277 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

943

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$15,681

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

2.4%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 353 $5,042
Pregabalin Generic 126 $2,763
Lidocaine Generic 17 $2,541
Diclofenac Sodium Generic 117 $1,473
Etodolac Generic 15 $634
Tizanidine Hcl Generic 30 $617
Baclofen Generic 50 $595
Cyclobenzaprine Hcl Generic 40 $496
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 23 $363
Tramadol Hcl Generic 41 $328

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$193,285

Of which drugs: $5,152

Medicare patients

514

Average age 74

Services billed

33,031

302 women, 212 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 33%
Ischemic heart disease 27%
Depression 26%
Chronic kidney disease 21%
Osteoporosis 19%
Atrial fibrillation 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 214 22,160 $2,271
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml Q9966 Office 300 6,335 $1,819
Injection, methylprednisolone acetate, 80 mg J1040 Office 85 106 $769
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 152 2,770 $249
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 11 48 $38

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Zilretta
  • Pacira Pharmaceuticals Incorporated $7
$7 — —
Exparel
  • Pacira Pharmaceuticals Incorporated $7
$7 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

64 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physical Medicine & Rehabilitation in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record